Additional European Equity News

AstraZeneca (AZN LN) - Co.'s Datroway has been recommended for approval in the EU as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy. (AstraZeneca)

BT Group (BT/A LN) - Co. has agreed to form a JV with Verizon (VZ), combining their respective international operations in a 50:50 joint venture, creating a new company focused on multinational connectivity. The JV will serve more than 3,000 customers across more than 180 countries, representing c. USD 4bln in combined annual revenue. Following the announcement, BT updated its guidance: cuts FY27 adj. revenue between GBP 17.1-17.6bln (prev. guided GBP 19-19.5bln) and Adj. EBITDA between GBP 8.1-8.2bln (prev. guided GBP 8.2-8.3bln). (BT Group)

Plus500 (PLUS LN) - Co. announces the launch of sports event-based contracts in the US, CFTC-regulated financial contracts that represent the highest-engagement category in prediction markets and significantly expand the Group's addressable market. (Plus500)

Adecco (ADEN SW) reiterated with Buy at Goldman Sachs

EssilorLuxottica (EL FP) reiterated with Buy at Goldman Sachs